Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

False Claims Act Suits May Become Harder After Supreme Court Ruling

Executive Summary

A U.S. Supreme Court ruling restricts when whistleblowers can sue someone for fraud against the government. But the opinion is limited to certain situations and may not affect suits brought against drug companies

You may also be interested in...



Supreme Court To Decide If Whistle Blowers Can Sue Based On State Data

The pharma industry had reason to cheer when the Supreme Court announced the next round of cases it would take up. Missing from the June 22 order list was a suit challenging reverse settlements between brand and generic manufacturers

Supreme Court To Decide If Whistle Blowers Can Sue Based On State Data

The pharma industry had reason to cheer when the Supreme Court announced the next round of cases it would take up. Missing from the June 22 order list was a suit challenging reverse settlements between brand and generic manufacturers

Off-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms

As industry weighs the potential impact of FDA's guidance on good reprint practices, stakeholders are suggesting alternate policy approaches that could give companies sufficient clarity on how to conduct off-label dissemination

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel